Home » Newsletters » BioWorld Asia

BioWorld Asia

May 31, 2000

View Archived Issues

Trial Of Antisoma's Theragyn Should Continue, Panel Says

Gene Defect In Rare Skin Disease Linked To Cell Survival Pathway

French Official Leads Petition Calling For Gene Patenting Ban

Alizyme Gets Compound Rights Thanks To Pharmaceutical Union

Israeli Officials Believe Biotech Deserves Extra Attention, Money

EuropaBio Plays Down Incident Of Accidental GM Seeds Release

IDM's Phase II Data In Ovarian Cancer Leads To Phase III Study

Scotia Presents Pivotal Data Showing Benefits Of Foscan

Other News To Note

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.